Eric D. Shaff, Director: Seres Therapeutics MCRB Sell · Filed 25/11/18

Trade details

Type: Insider sale
Amount: $3,754.1
Shares · price: 217 sh · $17.30 a share
Held after: 11,113 sh
Stock: Seres Therapeutics MCRB
Person: Eric D. ShaffDirector
Trade date: 25/11/15
Filed: 25/11/18
Days to filing: 3 days

Sold 1.9% of holdings

Share of holding sold: 1.9%

Seres Therapeutics trades, last 26 weeks

What else happened in Seres Therapeutics around then

Filed or reported within 30 days of the trade day · 25/10/16~25/12/15

Eric D. Shaff's recent trades

Eric D. ShaffDirector
Sell10b5-1 planSeres Therapeutics
Sell10b5-1 plan
Seres Therapeutics
MCRB
$1,950
259 sh
$1,950
Filed 05/19
Traded 05/18
Eric D. ShaffDirector
Sell10b5-1 planSeres Therapeutics
Sell10b5-1 plan
Seres Therapeutics
MCRB
$2,194
259 sh
$2,194
Filed 02/18
Traded 02/15
Eric D. ShaffDirector
Sell10b5-1 planSeres Therapeutics
Sell10b5-1 plan
Seres Therapeutics
MCRB
$3,613
217 sh
$3,613
Filed 25/08/19
Traded 25/08/18
Eric D. ShaffCEO and President
Sell10b5-1 planSeres Therapeutics
Sell10b5-1 plan
Seres Therapeutics
MCRB
$1,602
220 sh
$1,602
Filed 25/05/19
Traded 25/05/16
Eric D. ShaffCEO and President
Sell10b5-1 planSeres Therapeutics
Sell10b5-1 plan
Seres Therapeutics
MCRB
$10.3K
12,726 sh
$10.3K
Filed 25/02/19
Traded 25/02/18

Eric D. Shaff, Director — sold $3,754 of Seres Therapeutics MCRB · 1.9% of holdings · 10b5-1 plan | Whalegun